ZA200205596B - Octahydro-2H-Pyrido[1,2-A]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents
Octahydro-2H-Pyrido[1,2-A]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them.Info
- Publication number
- ZA200205596B ZA200205596B ZA200205596A ZA200205596A ZA200205596B ZA 200205596 B ZA200205596 B ZA 200205596B ZA 200205596 A ZA200205596 A ZA 200205596A ZA 200205596 A ZA200205596 A ZA 200205596A ZA 200205596 B ZA200205596 B ZA 200205596B
- Authority
- ZA
- South Africa
- Prior art keywords
- octahydro
- pyrido
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- ONHPOXROAPYCGT-UHFFFAOYSA-N 2,3,4,6,7,8,9,9a-octahydro-1h-pyrido[1,2-a]pyrazine Chemical class C1CNCC2CCCCN21 ONHPOXROAPYCGT-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0109260A FR2827288B1 (fr) | 2001-07-12 | 2001-07-12 | Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200205596B true ZA200205596B (en) | 2003-03-27 |
Family
ID=8865405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200205596A ZA200205596B (en) | 2001-07-12 | 2002-07-12 | Octahydro-2H-Pyrido[1,2-A]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6992085B2 (enEXAMPLES) |
| EP (1) | EP1275647B1 (enEXAMPLES) |
| JP (1) | JP3950018B2 (enEXAMPLES) |
| KR (1) | KR100485020B1 (enEXAMPLES) |
| CN (1) | CN1197863C (enEXAMPLES) |
| AR (1) | AR036166A1 (enEXAMPLES) |
| AT (1) | ATE254124T1 (enEXAMPLES) |
| AU (1) | AU2002300094B2 (enEXAMPLES) |
| BR (1) | BR0202681A (enEXAMPLES) |
| CA (1) | CA2394027C (enEXAMPLES) |
| DE (1) | DE60200089T2 (enEXAMPLES) |
| DK (1) | DK1275647T3 (enEXAMPLES) |
| EA (1) | EA005160B1 (enEXAMPLES) |
| ES (1) | ES2210219T3 (enEXAMPLES) |
| FR (1) | FR2827288B1 (enEXAMPLES) |
| HU (1) | HUP0202282A3 (enEXAMPLES) |
| MX (1) | MXPA02006699A (enEXAMPLES) |
| NO (1) | NO322966B1 (enEXAMPLES) |
| NZ (1) | NZ520120A (enEXAMPLES) |
| PL (1) | PL355034A1 (enEXAMPLES) |
| PT (1) | PT1275647E (enEXAMPLES) |
| SI (1) | SI1275647T1 (enEXAMPLES) |
| TR (1) | TR200302001T4 (enEXAMPLES) |
| ZA (1) | ZA200205596B (enEXAMPLES) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1611902A4 (en) * | 2003-04-03 | 2006-04-12 | Kyowa Hakko Kogyo Kk | MEANS FOR THE PREVENTION AND / OR TREATMENT OF NEUROPATHIC PAIN |
| MY141255A (en) * | 2003-12-11 | 2010-03-31 | Memory Pharm Corp | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP2008503560A (ja) * | 2004-06-22 | 2008-02-07 | ファイザー・プロダクツ・インク | ジアザビシクロ系のヒスタミン−３受容体アンタゴニスト |
| AU2006264966B2 (en) * | 2005-07-04 | 2013-02-21 | High Point Pharmaceuticals, Llc | Histamine H3 receptor antagonists |
| RU2442775C2 (ru) * | 2005-07-04 | 2012-02-20 | Хай Пойнт Фармасьютикалс, ЛЛС | Антагонисты гистаминовых н3-рецепторов |
| DE602007011904D1 (de) * | 2006-03-10 | 2011-02-24 | Neurogen Corp | Piperazinyl-oxoalkyl-tetrahydroisochinoline und verwandte analoga |
| KR100871691B1 (ko) | 2006-10-16 | 2008-12-05 | 삼성전자주식회사 | 병렬 비트 테스트 방법 및 그 방법을 사용하는 반도체메모리 장치 |
| US10870660B2 (en) | 2016-07-28 | 2020-12-22 | Shionogi & Co., Ltd. | Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect |
| CN111801330B (zh) | 2018-01-26 | 2024-04-05 | 盐野义制药株式会社 | 具有多巴胺d3受体拮抗作用的稠环化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3388128A (en) * | 1965-09-03 | 1968-06-11 | Allan R. Day | Substituted 1, 4-diazabicyclo [4. 4. 9] decanes |
| GB8518236D0 (en) * | 1985-07-19 | 1985-08-29 | Beecham Group Plc | Compounds |
| WO1994006794A1 (en) * | 1992-09-24 | 1994-03-31 | National Institutes Of Health | Aralkyl diazabicycloalkane derivatives for cns disorders |
| WO1996010570A1 (en) * | 1994-09-30 | 1996-04-11 | Pfizer Inc. | NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES |
| US6231833B1 (en) * | 1999-08-05 | 2001-05-15 | Pfizer Inc | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
| ES2274795T3 (es) * | 1999-07-19 | 2007-06-01 | Merck Frosst Canada Ltd. | Pirazinonas, composiciones que contienen tales compuestos. |
-
2001
- 2001-07-12 FR FR0109260A patent/FR2827288B1/fr not_active Expired - Fee Related
-
2002
- 2002-07-05 MX MXPA02006699A patent/MXPA02006699A/es active IP Right Grant
- 2002-07-10 JP JP2002201793A patent/JP3950018B2/ja not_active Expired - Fee Related
- 2002-07-11 TR TR2003/02001T patent/TR200302001T4/xx unknown
- 2002-07-11 NO NO20023345A patent/NO322966B1/no not_active IP Right Cessation
- 2002-07-11 ES ES02291745T patent/ES2210219T3/es not_active Expired - Lifetime
- 2002-07-11 SI SI200230005T patent/SI1275647T1/xx unknown
- 2002-07-11 DK DK02291745T patent/DK1275647T3/da active
- 2002-07-11 NZ NZ520120A patent/NZ520120A/en unknown
- 2002-07-11 EA EA200200663A patent/EA005160B1/ru not_active IP Right Cessation
- 2002-07-11 AT AT02291745T patent/ATE254124T1/de not_active IP Right Cessation
- 2002-07-11 EP EP02291745A patent/EP1275647B1/fr not_active Expired - Lifetime
- 2002-07-11 BR BR0202681-3A patent/BR0202681A/pt not_active IP Right Cessation
- 2002-07-11 PT PT02291745T patent/PT1275647E/pt unknown
- 2002-07-11 DE DE60200089T patent/DE60200089T2/de not_active Expired - Fee Related
- 2002-07-12 PL PL02355034A patent/PL355034A1/xx not_active Application Discontinuation
- 2002-07-12 HU HU0202282A patent/HUP0202282A3/hu unknown
- 2002-07-12 US US10/195,019 patent/US6992085B2/en not_active Expired - Fee Related
- 2002-07-12 CN CNB021241481A patent/CN1197863C/zh not_active Expired - Fee Related
- 2002-07-12 CA CA002394027A patent/CA2394027C/fr not_active Expired - Fee Related
- 2002-07-12 KR KR10-2002-0040727A patent/KR100485020B1/ko not_active Expired - Fee Related
- 2002-07-12 AU AU2002300094A patent/AU2002300094B2/en not_active Ceased
- 2002-07-12 ZA ZA200205596A patent/ZA200205596B/xx unknown
- 2002-07-12 AR ARP020102607A patent/AR036166A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401292A3 (en) | Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof | |
| HUP0401982A3 (en) | Indolizine derivates, process for their preparation and pharmaceutical compositions containing the compounds | |
| IL164857A (en) | 1-thia-4,8,diaza-spiro[4.5]decan-3-one compounds, process for preparation thereof and pharmaceutical compositions comprising them | |
| HUP0304082A3 (en) | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0401083A3 (en) | 4-amino-6-phenyl-pyrrolo [2,3-d] pyrimidine derivatives, pharmaceutical compositions containing them and process for the preparation of the compounds | |
| ZA200003702B (en) | Beta-carboline compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| IL145013A0 (en) | Tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL157940A0 (en) | Drugs containing triazaspiro [5.5] undecane derivatives as the active ingredient | |
| HUP0201122A3 (en) | Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0202624A3 (en) | Pyrazolo[4,3-d]pyrimidine-derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| PL367179A1 (en) | 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds | |
| HUP0001961A3 (en) | Substituted dimeric compounds, a process for their preparation and pharmaceutical compositions contaning them | |
| ZA200100864B (en) | Piperidine-4-sulphonamides compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200205596B (en) | Octahydro-2H-Pyrido[1,2-A]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HUP0402282A3 (en) | Triazolo[1,5a] quinoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
| AU2002300094A1 (en) | New octahydro-2H-pyrido[1,2-alpha]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200110314B (en) | Bicyclic amino-pyrazinones compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200202030B (en) | Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200202220B (en) | Indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| IL158035A0 (en) | 3, 7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds | |
| HUP0002277A3 (en) | Bicyclic amino-pyrazinone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200205666B (en) | N-benzylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200203086B (en) | Pyrimidin-4-one compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HUP0301466A3 (en) | 2-aminoalkyl-thieno [2,3-d] pyrimidines, process for their preparation and pharmaceutical compositions containing them | |
| HUP0004543A3 (en) | Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them |